Carrie McAdam-Marx, MSCI, PhD, RPh Dr. Carrie McAdam-Marx

Associate Professor

Department of Pharmacy Practice
Pharmaceutical Evaluation & Policy Division
Phone: (501) 526-5583
Office: RAHN Building, Room 6251

Education & Training

BS Pharmacy – University of Kansas
MS Hospital Pharmacy Administration – University of Minnesota
2 Year Administrative Residency – University of Minnesota Hospital & Clinic
PhD Health Policy – University of the Sciences Philadelphia
MS Clinical Investigation – University of Utah

Research & Scholarly Interests

Generating evidence to support policy-relevant decisions in diabetes pharmacotherapy. Research includes studies to demonstrate the real-world effectiveness of diabetes drug therapies and the effectiveness, value, and feasibility of clinical pharmacist-led comprehensive medication management in the primary care setting.

Honors & Awards

  • American Association of Colleges of Pharmacy New Faculty Award (2010)
  • International Society of Clinical Densitometry New Investigator Award (2011)
  • Career Development Award in Translational Comparative Effectiveness Research, National Cancer Institute (2011-2013)
  • Excellent Peer Review Recognition, Journal of Managed Care Pharmacy (2014, 2016)


  • Member, Academy of Managed Care Pharmacy (1998-current)
  • Member, International Society of Pharmacotherapy and Outcomes Research (2005-current)
  • Professional Member, American Diabetes Association (2008-current)
  • Member, American Association of Colleges of Pharmacy (2009-current)
  • Member, American College of Clinical Pharmacy (2009-current)


McAdam-Marx C, Dahal A, Jennings B, Singhal M, Gunning K (2015). The effect of a diabetes collaborative care management program on clinical and economic outcomes in patients with type 2 diabetes. Journal of Managed Care & Specialty Pharmacy, 21(6), 452-68.

Shane-McWhorter L, McAdam-Marx C, Lenert L, Petersen M, Woolsey S, Coursey JM, Whittaker TC, Hyer C, LaMarche D, Carroll P, Chuy L (2015). Pharmacist-provided diabetes management and education via a telemonitoring program. J Am Pharm Assoc (2003), 55(5), 516-26.

McAdam-Marx C, Nguyen H, Schauerhamer MB, Singhal M, Unni S, Ye X, Cobden D (2016). Glycemic Control and Weight Outcomes for Exenatide Once Weekly Versus Liraglutide in Patients with Type 2 Diabetes: A 1-Year Retrospective Cohort Analysis. Clin Ther, 38(12), 2642-2651.

Singhal M, Unni S, Schauerhamer M, Nguyen H, Hurd J, McAdam-Marx C (2017). Real-World Glycemic Control from GLP-1RA Therapy with and Without Concurrent Insulin in Patients with Type 2 Diabetes. J Manag Care Spec Pharm, 23(3), 267-275.

Biltaji E, Yoo M, Jennings B, Leiser J, McAdam-Marx C (2017). Outcomes Associated with Pharmacist-Led Diabetes Collaborative Drug Therapy Management in a Medicaid Population. J Pharm Health Serv Res. Mar;8(1):59-62.

NCBI Collection for Carrie McAdam-Marx

Curriculum Vitae